Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Monster Beverage Strong Sales Momentum Offset by Margin Pressure, RBC Says

Monster Beverage Strong Sales Momentum Offset by Margin Pressure, RBC Says

MT newswireMT newswire2026/11/06 19:27
03:27 PM EST, 11/06/2026 (MT Newswires) -- Monster Beverage (MNST) reported strong Q3 sales growth, with October trends reinforcing its momentum despite continued gross margin pressure, RBC Capital Markets said Friday in a note. International sales grew 28.1% to $1.20 billion in Q3, accounting for about 47% of total sales. Latin American sales were largely driven by Brazil, while APAC and EMEA also contributed meaningfully to topline performance, according to the note. Q3 gross margin declined to 54.7%, primarily due to higher aluminum can costs, an unfavorable geographical sales mix and elevated freight-in costs. Management expects these cost headwinds to persist through at least Q1 2027, with stronger gross margins expected in the back half of 2027, the brokerage said. RBC noted that the Nov. 1 pricing action, along with other measures, could help offset the pressure. The brokerage now expects 2026 consolidated sales growth of 19.3%, up from 17.7%, while its EPS estimate remains unchanged at $1.14. For 2027, it expects net sales growth of 10.6%, up from 10.5%, and EPS of $1.29, down from $1.30. RBC maintained its outperform rating and $50 price target on Monster Beverage. The company's shares were down 3.6% in Friday afternoon trading. Price: 46.13, Change: -1.71, Percent Change: -3.56
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq

Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.

智通财经•2026/11/09 06:12
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq